1.72  -0.16 (-8.51%)		07-01 15:50
Open: 1.84 High: 1.85 Volume: 38,080		Pre. Close: 1.88 Low: 1.7 Market Cap: 54(M)

Short term
Mid term
Targets	6-month :	18.14	1-year :	28.13
Resists	First :	15.53	Second :	24.09
Pivot price	7.62
Supports	First :	1.7	Second :	1.41
MAs	MA(5) :	2.08	MA(20) :	8.27
	MA(100) :	10.78	MA(250) :	10.61
MACD	MACD :	-2.7	Signal :	-1.9
%K %D	K(14,3) :	0.2	D(3) :	0.5
RSI	RSI(14): 33.7
52-week	High :	24.09	Low :	1.7

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ VACH ] has closed above bottom band by 28.8%. Bollinger Bands are 493.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 14 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	1.85 - 1.87	1.87 - 1.88
Low:	1.67 - 1.68	1.68 - 1.7
Close:	1.7 - 1.72	1.72 - 1.74

Voyager Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the healthcare or healthcare related sectors. Voyager Acquisition Corp. was incorporated in 2023 and is based in Brooklyn, New York.

Thu, 18 Jun 2026
Voyager Acquisition Corp (VACH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Wed, 17 Jun 2026
Voyager Acquisition Corp (VACH) Valuation: PE, PB & Fair Value Analysis - TradingKey

Thu, 11 Jun 2026
VERAXA Biotech to Debut as a Publicly Traded Company Pioneering Next-Generation Cancer Therapies on June 11, 2026 - The Manila Times

Thu, 11 Jun 2026
VERAXA Biotech (NASDAQ: VRXA) Completes Business Combination, Begins Trading on Nasdaq - TradingView

Tue, 09 Jun 2026
News On Voyager Acquisition Corp. (VACH) Now Under VRXA - Moomoo

Thu, 28 May 2026
VERAXA Biotech Secures $27.5M Financing, to Go Public Via SPAC - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Financial Services
Industry: Shell Companies
Shares Out	25 (M)
Shares Float	0 (M)
Held by Insiders	1 (%)
Held by Institutions	10.4 (%)
Shares Short	1 (K)
Shares Short P.Month	2 (K)

EPS	0.2
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.42
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-0.9 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	-91.1 %
Operating Cash Flow	2 (M)
Levered Free Cash Flow	272 (M)

PE Ratio	8.19
PEG Ratio	0
Price to Book value	-4.1
Price to Sales	0
Price to Cash Flow	27.71

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.